Atlas Trials

A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of JS401

Clinical trial NCT06041165 · UNKNOWN

Trial details

NCT number
NCT06041165
Sponsor
Shanghai Junshi Bioscience Co., Ltd.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Hyperlipidemia
Start date
2023-08-31
Primary completion
2024-06-29
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.